Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | Common Stock | 71.9K | $3.03M | $42.10 | Mar 3, 2025 | Direct |
ABEONA THERAPEUTICS INC. | Director | Common Stock | 47.1K | $254K | $5.38 | Jan 31, 2025 | Direct |
Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | Stock Ooption (Right to Buy) | 30.2K | Mar 1, 2025 | Direct | ||
Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | Stock Option (Right to Buy) | 2.35K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2025 | 4 | -$377K | 4 | Mar 4, 2025 | EVP and Chief Medical Officer |
ABEO | ABEONA THERAPEUTICS INC. | Jan 31, 2025 | 1 | $0 | 4 | Feb 3, 2025 | Director |
ABEO | ABEONA THERAPEUTICS INC. | Aug 13, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
ABEO | ABEONA THERAPEUTICS INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
RARE | Ultragenyx Pharmaceutical Inc. | May 2, 2024 | 1 | -$15.5K | 4 | May 3, 2024 | EVP and Chief Medical Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Apr 18, 2024 | 1 | -$6.26K | 4 | Apr 19, 2024 | EVP and Chief Medical Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2024 | 4 | -$66.6K | 4 | Mar 5, 2024 | EVP and Chief Medical Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Sep 27, 2023 | 1 | $0 | 4 | Sep 29, 2023 | EVP and Chief Medical Officer |
RARE | Ultragenyx Pharmaceutical Inc. | May 1, 2023 | 2 | $0 | 4 | May 2, 2023 | EVP and Chief Medical Officer |
RARE | Ultragenyx Pharmaceutical Inc. | May 1, 2023 | 0 | $0 | 3 | May 2, 2023 | EVP and Chief Medical Officer |